Doctors and researchers at the University of Missouri and MU Health Care have introduced a groundbreaking new tool to help people diagnosed with respiratory conditions breathe a little easier.

By using the FDA-approved hyperpolarized xenon gas as an inhaled contrast for MRI scans, doctors can accurately measure lung ventilation, or function, in high detail. The gas is now produced at MU Health Care and used in a highly advanced MRI suite.

This new diagnostic tool will help people with respiratory conditions —including asthma, COPD, cystic fibrosis and more — diagnose and treat their illnesses earlier.

Patients inhale the non-reactive xenon gas and hold their breath for the 10-to-15-second scan. The images show how a breath of air is drawn into the lungs, and gives doctors a better understanding of lung function, leading to faster and better treatments.

MU Health Care is the second health system in the United States to use the gas, called XENOVIEW, in clinical patient scans.





Subscribe now ➤ https://bit.ly/2NNQiyM

For more great content from HEC Media check us out at:
Facebook ➤ http://bit.ly/1WPZEek
Twitter ➤ http://bit.ly/22qZDNU
Instagram ➤ http://bit.ly/1THSOnM